A neurologist and a rheumatologist sat down with Patient Care editors to talk about their focus on balance in the gut microbiome as an essential element of clinical care.
The FDA approved today the first drug that targets the pathophysiolgic process responsible for Alzheimer disease and the first drug since 2003 to be approved for any Alzheimer treatment.
Healthcare providers are advised to weigh carefully the risks vs benefits of continuing lamotrigine therapy and not to substitute with another drug from the class.
Gradually worsening weakness in the shoulders, neck, and face of 4-5 days' duration is the presenting complaint of a man in his 60s. ED physician Brady Pregerson, MD, asks, "What's your diagnosis?"
In this Medical News Minute, Dr Bobby Lazzara looks at the impact of PPI use on incident dementia in the elderly.
This brief slide show toplines key research from the 58th Annual Scientific Meeting of the American Headache Society, June 1-4, 2016.
"Keep calm and carry on" suggests a thoughtful gastroenterologist whose patients continue to ask for reassurance.
An association was found between headache or non-migrainous headache and later dementia. Not so for migraine.
Diseases of the nervous system and sense organs-particularly eye and ear disorders-are prime diagnoses that bring patients to your primary care practice.